Enifer Secures €12 million grant to build a first-of-its-kind mycoprotein ingredient factory

Image courtesy of Enifer

Investments & Finance

Enifer Receives €12M EU Grant for “First-of-its-Kind” Mycoprotein Facility in Finland

Finnish biotech startup Enifer announces that it has received a grant worth over €12 million from the European Union’s NextGenerationEU programme, to construct its first commercial-scale mycoprotein facility in the Uusimaa region (the exact location has not been revealed). Enifer has developed a mycoprotein ingredient called PEKILO using fungal fermentation, industrial byproducts, and waste streams. The plant’s total construction cost is €30 million and is set to be completed by the end of 2025, with production starting in 2026. Once operational, the biotech claims that the mycoprotein factory, the first-of-its-kind, will be ready to produce three million kilograms of PEKILO per year — equivalent to the protein yield of 30,000 cows while emitting at least 20 times fewer carbon emissions. “This plant will be a critical …